COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02670967
Recruitment Status : Unknown
Verified August 2015 by St. Michael's Hospital, Toronto.
Recruitment status was:  Active, not recruiting
First Posted : February 2, 2016
Last Update Posted : February 2, 2016
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

Brief Summary:

The present study conducted a meta-analysis of 22 randomly controlled trials to assess the effects of soluble fiber intake on blood pressure in human subjects.

Using the Cochrane Handbook for Systematic Reviews of Intervention, a systematic review and meta-analysis was conducted. Information regarding study methods, characteristics, mean BP and standard deviations were extracted The data from each study were pooled using a random effects model to estimate the effects of soluble fiber consumption on blood pressure.

Condition or disease Intervention/treatment
Blood Pressure Dietary Supplement: Soluble Fibre

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Time Perspective: Retrospective
Official Title: Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials
Study Start Date : September 2014
Estimated Primary Completion Date : September 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dietary Fiber

Primary Outcome Measures :
  1. Systolic Blood Pressure [ Time Frame: 4 weeks ]
  2. Diastolic Blood Pressure [ Time Frame: 4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy, hypertensive, hypercholesterolaemic, diabetic

Inclusion Criteria:

  • Randomized Controlled Trials
  • Parallel or Crossover Design
  • Duration: >3 weeks
  • Human trials
  • Viscous (soluble) fiber
  • Viable endpoint data
  • Articles published in English

Exclusion Criteria:

  • Non-human
  • Non-randomized
  • Lack of control
  • Less than 4 weeks in duration
  • No viable endpoint data

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02670967

Layout table for location information
Canada, Ontario
The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre
Toronto, Ontario, Canada, M5C 2T2
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Layout table for investigator information
Principal Investigator: Vladimir Vuksan, PhD St. Michael's Hospital, Toronto
Study Director: Kashif Khan, BSc St. Michael's Hospital, Toronto
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: St. Michael's Hospital, Toronto Identifier: NCT02670967    
Other Study ID Numbers: FIberBPMeta
First Posted: February 2, 2016    Key Record Dates
Last Update Posted: February 2, 2016
Last Verified: August 2015